Osivax and GC Biopharma unveiled a strategic collaboration aimed at developing a new-generation influenza vaccine. The vaccine is set to combine OVX836 and GC FLU. Osivax gained rights for pursuing a combo shot.
Older adults are facing four vaccine decisions this fall, while the national vaccine schedule still lists a 2025 date. Flu and pneumonia deaths have dropped for 25 years, but one American age group recorded a rise.
Older Adults Face Four Vaccine Decisions This Fall While the Federal Schedule Still Carries a 2025 Date Medical Daily
COVID is spreading again in the Bay Area. Here's who should take precautions The Press Democrat
COVID Is Back: Does Anyone Care Anymore? The People's Pharmacy
Is There a Summer COVID Surge? With Cases Rising in Nearly Every State, Watch for These Symptoms TODAY.com
One American Age Group Went the Wrong Way While Flu and Pneumonia Deaths Fell for 25 Years Medical Daily